KCAS Bio is excited to announce our participation in EUROTOX 2024, held in the vibrant city of Copenhagen, Denmark. As a leading event in the field of toxicology, EUROTOX brings together scientists, researchers, and industry experts to discuss the latest advancements and challenges in toxicology and safety assessment. We are…

KCAS Bio is excited to announce our participation in the AAPS Summer Scientific Forum, held in Kansas City, Missouri. As a leading event in pharmaceutical science, this forum provides a unique opportunity for professionals to share knowledge, explore innovative research, and collaborate on the latest advancements in the industry. We…

KCAS Bio is happy to announce our participation in the 12th edition of the Antibody Industrial Symposium (AIS), taking place in Montpellier, France. As a premier event in the antibody and therapeutic development sector, AIS offers a unique platform for scientific exchange, collaboration, and innovation. We are excited to be…

KCAS Bio is excited to announce our participation in the 72nd ASMS Conference on Mass Spectrometry and Allied Topics, taking place in Anaheim, California, from June 2-6, 2024. This prestigious event brings together experts and enthusiasts from around the world to discuss the latest advancements and innovations in mass spectrometry.

KCAS Bio is thrilled to announce our participation in the BIO International Convention 2024 in San Diego, California. This premier event, set for June 3-6, brings together the brightest minds in the biotech and pharmaceutical industries to discuss the latest innovations and advancements. As leaders in bioanalytical services, we are…

Charcot, Gehrig, Hawking: A Journey Through ALS When you hear the names Charcot, Gehrig, and Hawking, what comes to mind? These names are all linked by a shared thread: Amyotrophic Lateral Sclerosis, or ALS. ALS, also known as Charcot disease, is named after Jean-Martin Charcot, a neurologist from the Pitié-Salpêtrière…

Dom and John welcome special guests, Habibi Goudarzi and Rochelle Burke to episode #77 of “The Weekly Bioanalysis”, where they discuss the progression of bioanalytical needs for non-GLP Studies, from Early PK to readiness for GLP Tox Studies. These specialists from the KCAS Bio team begin with an introduction to…

Neutralizing antibodies (NAbs) are a subset of Anti-drug antibodies (ADAs) that play an important role in understanding the efficacy and safety of a drug product. While most drugs are associated with low risk and do not require a validated NAb assay prior to testing Phase 3 samples, drugs associated with…

In conjunction with Cytek and Bio-Rad, KCAS Bio will host an open house on Tuesday, June 18th from 10:00am to 5:00+pm at: KCAS BioSpring House Innovation Park727 Norristown Road. Lower Gwynedd, PA 19002Parking is Directly Next to Building 4 and Building This packed event includes: Presentations: KCAS Bio, Cytek and Bio-Rad will…

The age of therapeutic conjugation is upon us! Bioanalysis for support of next-generation Antibody Drug Conjugates (ADCs) and Antibody siRNA Conjugates (ARCs) have exploded recently due to the efficacy and safety that these therapies offer for immuno-oncology, rare diseases, vaccines, and potentially many other diseases. Recently, we have seen the…

For episode #8 of “The Conversational Flow” podcast, Brian and Adam spend the time discussing Receptor Occupancy Testing in Clinical Trials. Receptor occupancy (RO) assays are important in clinical trials because they provide valuable information about a drug’s binding characteristics and mechanism of action. Our hosts begin by outlining the…

KCAS Bio is excited to invite you to join us this week in San Francisco, CA during AAPS NBC where Nassouh Mourabet will be giving a presentation entitled “Spectral Unmixing Impact Comparison Across Immunophenotyping Panels and Matrices”. Nassouh Mourabet is a Scientist III in the Flow Cytometry department at KCAS…